BA
The Boeing Company
BA offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CTAS
Cintas Corporation
CTAS has the edge over BA overall, supported by lower modeled downside.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
CTAS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
CTAS's revenue, profitability, cash flow and balance sheet are all currently healthy.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over CTAS in the historical PE scenario, which offers more potential upside but is not a forecast.
CTAS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 35x | $179 | -21% |
| Fair | 39x | $198 | -13% |
| Forward | 40x | $228 | — |
| Current | 45x | $228 | — |
| Expensive | 47x | $239 | +4.9% |
Historical ranges are pointers, not guarantees.
CTAS's PE is in its expensive range at 45x. If earnings grow as analysts expect, today's price would be 40x next year's earnings, in its fair range.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
CTAS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Moderate | |
| High |
Analysts expect earnings and revenue growth for CTAS, with profitability improving.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
CTAS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.71 | +13% |
| Q3 2026 | $5.07 | +13% |
| Q2 2026 | $4.91 | +12% |
| Q1 2026 | $4.73 | +9.5% |
| Q4 2025 | $4.62 | +11% |
| Q3 2025 | $4.50 | +14% |
| Q2 2025 | $4.40 | +16% |
| Q1 2025 | $4.32 | +19% |
| Q4 2024 | $4.15 | +20% |
CTAS has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
CTAS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3B | +11% |
| Q2 2026 | $2.9B | +8.9% |
| Q1 2026 | $2.8B | +8.9% |
| Q4 2025 | $2.8B | +9.3% |
| Q3 2025 | $2.7B | +8.7% |
| Q2 2025 | $2.7B | +8% |
| Q1 2025 | $2.6B | +8.4% |
| Q4 2024 | $2.6B | +7.8% |
CTAS's revenue has grown year over year for 22 quarters in a row: $3B last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | +0.9 points |
| Q2 2026 | 23% | +0.8 points |
| Q1 2026 | 23% | -0.2 points |
| Q4 2025 | 23% | +0.3 points |
| Q3 2025 | 23% | +0.3 points |
| Q2 2025 | 22% | +0.2 points |
| Q1 2025 | 23% | +1.7 points |
| Q4 2024 | 23% | +2.1 points |
CTAS has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over CTAS on cash flow, with more consistent year-over-year improvement.
CTAS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464.8M | +49% |
| Q2 2026 | $613.1M | +18% |
| Q1 2026 | $530.6M | +1.6% |
| Q4 2025 | $425M | +25% |
| Q3 2025 | $312.5M | -16% |
| Q2 2025 | $521.1M | -12% |
| Q1 2025 | $522.1M | -5.1% |
| Q4 2024 | $340M | +14% |
CTAS's free cash flow has been positive every quarter for seven years: $2B over the past year, up 20% from the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CTAS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -1.9M shares |
| 1 year | -1.2% | -5M shares |
| 3 years | -2.4% | -10M shares |
| 5 years | -4.6% | -19.5M shares |
| Available history | -5.8% | -25.1M shares |
CTAS has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $315.7M |
| Q2 2026 | $18.9M |
| Q1 2026 | $31.6M |
| Q4 2025 | $635.6M |
| Q3 2025 | $266.1M |
| Q2 2025 | $256.7M |
| Q1 2025 | $26.6M |
| Q4 2024 | $36.7M |
CTAS spent $1B buying back its own shares over the past year, up 71% from the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
CTAS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 0.8x | Very low |
| Q4 2025 | 0.9x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.8x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Very low |
CTAS has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
CTAS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.7 | Neutral |
| Stochastic | 80.2 | Overbought |
CTAS's weekly RSI is 69 (neutral) and its Stochastic is 80 (overbought).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over CTAS on valuation relative to its sector.
CTAS PE vs Industrials Sector
| Metric | CTAS | Sector median | Relative |
|---|---|---|---|
| PE | 45x | 24x | 86% above |
| PE % | 77 | 58 | 19 pts above |
CTAS is trading at 45x earnings, a 86% premium to the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
CTAS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $212.9 | 6.9% above |
| 20 week MA | $204.5 | 11% above |
| 50 week MA | $191.7 | 19% above |
| 100 week MA | $198.1 | 15% above |
| 200 week MA | $175.2 | 30% above |
CTAS has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
CTAS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $67.3 | $84.6 | +26% |
| 2021 | $84.6 | $108.8 | +29% |
| 2022 | $108.8 | $114.3 | +5.1% |
| 2023 | $114.3 | $150.7 | +32% |
| 2024 | $150.7 | $183.4 | +22% |
| 2025 | $183.4 | $191.1 | +4.2% |
| 2026 YTD | $191.1 | $227.5 | +19% |
CTAS has the edge over BA on returns for 2026, with the stronger performance.